Samuels T, Lovett M C, Campbell I T, Makin C, Davies J, Jenkins S A, Baxter J N
University Department of Anaesthesia, Royal Liverpool Hospital.
Gut. 1994 Oct;35(10):1459-63. doi: 10.1136/gut.35.10.1459.
Arterial oxygen tension (Pao2), carbon dioxide tension (PaCO2), and vital capacity were measured preoperatively and one day postoperatively in patients with chronic hepatic cirrhosis having elective oesophageal injection sclerotherapy under general anaesthesia. The results were compared with the same measurements made in patients with chronic cirrhosis anaesthetised and scheduled to have injection sclerotherapy under general anaesthesia but who, because of variceal obliteration, only had an oesophagogastroscopy. In the injected group PaO2 decreased by 9.3 (3.0) mm Hg (1.2 (0.4) kPa) (mean (SEM)) (p < 0.02) but in the controls did not change. The difference between the two groups was significant (p < 0.02). Vital capacity decreased by 0.39 (0.08) litres (BTPS) (p < 0.01) after injection sclerotherapy but in the controls did not change. Again the difference between the two groups was significant (p < 0.02). In the injected group there was a significant correlation between the change in PaO2 and the percentage change in vital capacity (r = 0.787, p < 0.01) but no such relation was seen in control subjects. These results suggest that oesophageal injection sclerotherapy is associated with a restrictive defect in respiratory function one day after the injection caused, possibly, by sclerosant embolising to the lung.
对择期在全身麻醉下接受食管注射硬化疗法的慢性肝硬化患者,在术前及术后一天测量动脉血氧分压(Pao2)、二氧化碳分压(PaCO2)和肺活量。将结果与在全身麻醉下接受硬化疗法麻醉且计划进行该疗法但因静脉曲张闭塞仅接受食管胃镜检查的慢性肝硬化患者的相同测量结果进行比较。在注射组中,PaO2下降了9.3(3.0)mmHg(1.2(0.4)kPa)(均值(标准误))(p<0.02),但对照组未发生变化。两组间差异具有显著性(p<0.02)。注射硬化疗法后肺活量下降了0.39(0.08)升(体温、气压、饱和水蒸气压条件下)(p<0.01),但对照组未发生变化。两组间差异同样具有显著性(p<0.02)。在注射组中,PaO2的变化与肺活量的百分比变化之间存在显著相关性(r = 0.787,p<0.01),但在对照组中未观察到这种关系。这些结果表明,食管注射硬化疗法与注射后一天出现的呼吸功能限制性缺陷有关,这可能是由于硬化剂栓塞到肺部所致。